Cooperate with Yangtze River Pharmaceutical Group
Release time:
2023-04-19 23:51
User reviews and feedback:
Nanjing Baidier Biopharmaceutical Co., Ltd. transferred the raw material and capsule development technology of Lenalidomide to our company. This technology is mature and stable, with reliable quality. After our company acquired the raw material development technology and capsule development technology, we completed further industrial scale-up production based on this foundation, successfully completed multiple batches of validation production, and passed the bioequivalence study. In July 2020, we obtained the production license. This technology transfer has realized the key process from research and development to production, playing a very important role in the quality and market launch of our products. On September 18, the Internet hospital sold the first box of Lenalidomide capsules (Youjia) produced by Yangtze River Pharmaceutical Group Co., Ltd., marking the successful transition from implementation to market sales.
Related News